期刊文献+

Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients 被引量:10

Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients
下载PDF
导出
摘要 AIM:To investigate prevalence,type and time of onset of extraintestinal manifestations(EIMs)in a series of Italian inflammatory bowel disease(IBD)patients.METHODS:Data of 811 IBD consecutive patients,first referred to our Centre from 2000 to 2011,were retrospectively evaluated.RESULTS:Eight hundred and eleven IBD patients(437M,374 F)were studied:595 ulcerative colitis(UC)(73.4%)and 216 Crohn’s disease(CD)(26.6%).Among these,329(40.6%)showed EIMs:210 UC(35.3%)and119 CD(55.1%)(P<0.0001).Considering the time of the diagnosis of IBD,37 EIMs(11.2%)were developed before,229(69.6%)after and 63(19.2%)were simultaneous.The type of EIM were as follows:240 musculoskeletal(29.6%),in 72 CD patients and in 168 UC(P<0.0001);47 mucocutaneous(5.8%),in 26 CD and in21 UC(P=0.0049);26 ocular(3.2%),in 16 CD and in10 UC(CD 7.4%vs UC 1.7%,P=0.0093);6 hepatobiliary(0.8%);10 endocrinological(1.2%).In particular,with regards to the involvement of the musculoskeletal system,arthritis Type 1 was found in 41 CD(19%)and in 61 UC(10.2%)(P=0.0012)and Type 2 in 25 CD(11.6%)and in 100 UC(16.8%)(P=0.0012).CONCLUSION:Mucocutaneous manifestations,arthritis Type 1 and uveitis were significantly more frequent in CD than UC.The complications of the musculoskeletal system were the mostly observed ones,often with symptoms more severe than intestinal ones,confirming the need for close cooperation with rheumatologists. AIM: To investigate prevalence, type and time of onset of extraintestinal manifestations (EIMs) in a series of Italian inflammatory bowel disease (IBD) patients.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第46期17463-17467,共5页 世界胃肠病学杂志(英文版)
关键词 Crohn’s DISEASE Extraintestinal MANIFESTATIONS Inf Crohn&#x02019 s disease Extraintestinal manifestations Inflammatory bowel diseases Musculoskeletal manifestations Ulcerative colitis
  • 相关文献

参考文献5

二级参考文献261

  • 1Kazuhiko Nakamura,Kuniomi Honda,Takahiro Mizutani,Hirotada Akiho,Naohiko Harada.Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules[J].World Journal of Gastroenterology,2006,12(29):4628-4635. 被引量:18
  • 2S Desplat-Jégo,C Johanet,A Escande,J Goetz,N Fabien,N Olsson,E Ballot,J Sarles,JJ Baudon,JC Grimaud,M Veyrac,P Chamouard,RL Humbel.Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: Results of a multicent[J].World Journal of Gastroenterology,2007,13(16):2312-2318. 被引量:24
  • 3[1]Veloso FT,Carvalho J,Magro F.Immune-related systemic manifestations of inflammatory bowel disease.A prospective study of 792 patients.J Clin Gastroenterol 1996; 23:29-34
  • 4[2]Das KM.Relationship of extraintestinal involvements in inflammatory bowel disease:new insights into autoimmune pathogenesis.Dig Dis Sci 1999; 44:1-13
  • 5[77]Viereck V,Emons G,Lauck V,Frosch KH,Blaschke S,Grundker C,Hofbauer LC.Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.Biochem Biophys Res Commun 2002;291:680-686
  • 6[78]Vidal NO,Brandstrom H,Jonsson KB,Ohlsson C.Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells:down-regulation by glucocorticoids.J Endocrinol 1998; 159:191-195
  • 7[79]Redlich K,Hayer S,Maier A,Dunstan CR,Tohidast-Akrad M,Lang S,Turk B,Pietschmann P,Woloszczuk W,Haralambous S,Kollias G,Steiner G,Smolen JS,Schett G.Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin.Arthritis Rheum 2002; 46:785-792
  • 8[80]Bernstein CN,Bector S,Leslie WD.Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease.Am J Gastroenterol 2003; 98:2468-2473
  • 9[81]Schulte CM,Dignass AU,Goebell H,Roher HD,Schulte KM.Genetic factors determine extent of bone loss in inflammatory bowel disease.Gastroenterology 2000; 119:909-920
  • 10[82]Haderslev KV,Tjellesen L,Sorensen HA,Staun M.Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease.Gastroenterology 2000; 119:639-646

共引文献58

同被引文献49

引证文献10

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部